Navigation Links
New Regulations for Hospice Provision Published by CMS
Date:6/5/2008

tion day of the new rule.

In his remarks at the NHPCO meeting, Dr. Straub said, "This rule will improve quality of care overall and provide flexibility for hospices to do the work they need to do - and this is a framework we must build on."

Since the proposed CoPs were released three years ago, NHPCO has been actively developing initiatives and programs focusing on quality and performance measurement. These include NHPCO's Quality Partners initiative and several research, data collection and benchmarking tools available to hospice providers.

"The hospice community has eagerly awaited the publication of the new Conditions of Participation since the proposed rule was released in May of 2005," remarked J. Donald Schumacher, president and CEO of NHPCO. "The new CoPs will ensure a framework of quality that benefit patients, families, and the organizations providing care at life's end. The new CoPs along with tools and resources available from NHPCO will help all providers continue to strive for the highest levels of quality and access."

More than 1.3 million dying Americans received care from the nation's hospice providers last year. This number has risen and continues to grow as more patients learn of the wide range of beneficial services and the compassionate care that hospice offers.

Hospice care is considered to be the model for high-quality care at the end of life. Hospice involves a team-oriented approach to care that includes expert medical attention, pain-and-symptom management, and emotional and spiritual support. The quality of a person's life is emphasized, not the duration. Moreover, services and support are provided to family caregivers, in addition to the patient.

The economic value of hospice care has been validated by research. An independent study released late last year by Duke University found that the use of hospice saved Medicare an average of $2,300 per patient who received this care.

Noted Schumacher
'/>"/>

SOURCE National Hospice and Palliative Care Organization
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. AHIP Statement on CMS Proposed Medicare Marketing Regulations
2. APIC Conference to Address New CMS Regulations
3. APIC Conference to address new CMS regulations
4. Golden State Medical Supply Selects IBM Technology to Comply With California Prescription Drug Pedigree Regulations
5. Food Policy Institute primer on food imports and regulations
6. APHA Says New Ozone Regulations a Missed Opportunity to Protect Publics Health
7. Just Completed Studies Reveal Impact of New Medicare Reimbursement Regulations
8. Philadelphia Insurance Companies Launches Home Health Care and Hospice Products
9. The Norma F. Pfriem International Fellowship in Hospice and Palliative Care Nursing
10. National hospice study reveals gaps in service
11. While Hospice Care Is Growing, Not All Have Access
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 2Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 3Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 4Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 5Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 6Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 7Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 8Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 9Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 10Health News:New Data Support Long-term Use of Antiepileptic Drug Vimpat(R) (Lacosamide) (C-V) 11Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 2Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 3Health News:Data from Phase 1 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Non-Hodgkins Lymphoma 4Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 2Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 3Health News:Social Networking Community Reaches Out to Persons With Illnesses and Disabilities 4Health News:Zogenix Increases Series B Preferred Stock Financing to $71 Million, Raising $35 Million in Second Tranche 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 2Health News:New DIA Vision And Mission Coincides With Start of Paul Pomerantz Tenure As Worldwide Executive Director 3
Breaking Medicine Technology:Shared Imaging Earns The Joint Commission's Accreditation for Ambulatory Health Care 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 1Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 2Exclusive Marketplace for Nursing Professionals Launched by Nurses Service Organization 47502 3Say Cheese With Milk 47498 1Say Cheese With Milk 47498 2Say Cheese With Milk 47498 3Say Cheese With Milk 47498 4Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 1Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 2Edward Diehl Receives Outstanding Achievement Award From the American College of Addiction Treatment Administrators 28ACATA 29 47495 3